U.S. Markets open in 4 hrs 19 mins
  • S&P Futures

    3,603.25
    +27.25 (+0.76%)
     
  • Dow Futures

    29,821.00
    +275.00 (+0.93%)
     
  • Nasdaq Futures

    11,950.25
    +45.00 (+0.38%)
     
  • Russell 2000 Futures

    1,839.90
    +22.80 (+1.25%)
     
  • Crude Oil

    43.41
    +0.35 (+0.81%)
     
  • Gold

    1,822.60
    -15.20 (-0.83%)
     
  • Silver

    23.45
    -0.18 (-0.75%)
     
  • EUR/USD

    1.1888
    +0.0042 (+0.3566%)
     
  • 10-Yr Bond

    0.8570
    0.0000 (0.00%)
     
  • Vix

    22.18
    -1.52 (-6.41%)
     
  • GBP/USD

    1.3364
    +0.0042 (+0.3141%)
     
  • USD/JPY

    104.2300
    -0.2580 (-0.2469%)
     
  • BTC-USD

    19,030.99
    +579.02 (+3.14%)
     
  • CMC Crypto 200

    377.04
    +15.61 (+4.32%)
     
  • FTSE 100

    6,392.41
    +58.57 (+0.92%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Ocular Therapeutix: 3Q Earnings Snapshot

·1 min read

BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Thursday reported a loss of $11.9 million in its third quarter.

The Bedford, Massachusetts-based company said it had a loss of 21 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The biotechnology company posted revenue of $5.9 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $5.8 million.

Ocular Therapeutix shares have more than tripled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12, more than tripling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL